000			01736nam a22002777a 4500
003			OSt
005			20250219174641.0
008			250219b |||||||| |||| 00| 0 hin d
020			_a9781853178900
040			_aNISER LIBRARY _beng _cNISER LIBRARY
041			_aEnglish
082			_a616.155.392 _bCAR-C
245			_aChronic myeloid leukemia : _bbiology and treatment
260			_aLondon : _bMartin Dunitz Ltd, _c2001.
300			_axv, 528 pages
504			_aIncludes bibliographical references and index.
520			_aTremendous advances have been made in our understanding of the molecular mechanisms involved in human disease, and it can be argued that in this context chronic myeloid leukaemia is perhaps the best understood of all human malignancies. This text, from a world-renowned team of experts in CML, examines these advances and the implications they have for the management of this disease. Topics covered include the molecular and cellular biology of CML, conventional chemotherapy and interferon therapy, and recent developments in allografting and autografting. The book concludes with an overview of novel target-directed therapies, particularly the recent results with the tyrosine kinase inhibitor, STI571. This comprehensive text will be essential reading for all haemato-oncologists involved in this field.
650			_aAcute myeloid leukemia
700			_aCarella, Angelo M. _eeditor
700			_aDaley, George Q. _eeditor
700			_aEaves, Connie J. _eeditor
700			_aGoldman, John M. _eeditor
700			_aHehlmann, Rüdiger _eeditor
856			_3Reviews _uhttps://www.goodreads.com/book/show/7256258-chronic-myeloid-leukemia?ref=nav_sb_ss_1_13#CommunityReviews
942			_2udc _cBK
999			_c35705 _d35705